Literature DB >> 24150028

ACOG Committee Opinion No. 577: Understanding and using the U.S. Selected Practice Recommendations for Contraceptive Use, 2013.

.   

Abstract

The U.S. Selected Practice Recommendations for Contraceptive Use, 2013 (U.S. SPR), issued by the Centers for Disease Control and Prevention is a companion piece to the Centers for Disease Control and Prevention's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. The U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, provides guidance for which contraceptive methods are safe for women with selected characteristics and medical conditions, whereas the U.S. SPR offers guidance on how to use these methods most effectively. The American College of Obstetricians and Gynecologists endorses the U.S. SPR and encourages its use by Fellows; providers should always consider the specific clinical situation when applying these guidelines to individual clinical care.

Entities:  

Mesh:

Year:  2013        PMID: 24150028     DOI: 10.1097/01.AOG.0000437383.81092.4e

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring.

Authors:  J Stewart; W J Breslin; B K Beyer; K Chadwick; L De Schaepdrijver; M Desai; B Enright; W Foster; J Y Hui; G J Moffat; B Tornesi; K Van Malderen; L Wiesner; C L Chen
Journal:  Ther Innov Regul Sci       Date:  2015-10-08       Impact factor: 1.778

Review 2.  Prenatal contraceptive counseling and method provision after childbirth.

Authors:  Anita L Nelson
Journal:  Open Access J Contracept       Date:  2015-05-13

3.  Medicaid Claims for Contraception Among Women With Medical Conditions After Release of the US Medical Eligibility Criteria for Contraceptive Use.

Authors:  Toyya A Pujol; Nicoleta Serban; Julie Swann; Melissa Kottke
Journal:  Prev Chronic Dis       Date:  2019-01-03       Impact factor: 2.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.